GSK3β-activation is a point of convergence for HIV-1 and opiate-mediated interactive neurotoxicity.

作者: Ruturaj R. Masvekar , Nazira El-Hage , Kurt F. Hauser , Pamela E. Knapp

DOI: 10.1016/J.MCN.2015.01.001

关键词:

摘要: Infection of the CNS with HIV-1 occurs rapidly after primary peripheral infection. can induce a wide range neurological deficits, collectively known as HIV-1-associated neurocognitive disorders. Our previous work has shown that selected neurotoxic effects induced by individual viral proteins, Tat and gp120, HIV+ supernatant are enhanced co-exposure to morphine. This mimics co-morbid observed in opiate-abusing patients. Although there is correlation between opiate drug abuse progression disorders, mechanisms underlying interactions opiates remain obscure. Previous studies have induces through abnormal activation GSK3β. Interestingly, expression GSK3β be elevated brains young abusers indicating also linked neuropathology seen Thus, we hypothesize point convergence for HIV- opiate-mediated interactive effects. Neuronal cultures were treated from HIV-1SF162-infected THP-1 cells, presence or absence morphine inhibitors. results show inhibitors, including valproate small molecule significantly reduce HIV-1-mediated outcomes, negate result cell death, suggesting GSK3β-activation an important potential therapeutic target deficits.

参考文章(105)
Phillip K. Peterson, Genya Gekker, Ronald Schut, Shuxian Hu, Henry H. Balfour, Chun C. Chao, Enhancement of HIV-1 Replication by Opiates and Cocaine: The Cytokine Connection Advances in Experimental Medicine and Biology. ,vol. 335, pp. 181- 188 ,(1993) , 10.1007/978-1-4615-2980-4_26
U Arvidsson, M Riedl, S Chakrabarti, JH Lee, AH Nakano, RJ Dado, HH Loh, PY Law, MW Wessendorf, R Elde, Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord The Journal of Neuroscience. ,vol. 15, pp. 3328- 3341 ,(1995) , 10.1523/JNEUROSCI.15-05-03328.1995
Ying Wang, Michael G. White, Cagla Akay, Rebecca A. Chodroff, Jonathan Robinson, Kathryn A. Lindl, Marc A. Dichter, Yang Qian, Zixu Mao, Dennis L. Kolson, Kelly L. Jordan-Sciutto, Activation of cyclin-dependent kinase 5 by calpains contributes to human immunodeficiency virus-induced neurotoxicity Journal of Neurochemistry. ,vol. 103, pp. 439- 455 ,(2007) , 10.1111/J.1471-4159.2007.04746.X
Sylvia Fitting, Ruqiang Xu, Cecilia Bull, Shreya K. Buch, Nazira El-Hage, Avindra Nath, Pamela E. Knapp, Kurt F. Hauser, Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons. American Journal of Pathology. ,vol. 177, pp. 1397- 1410 ,(2010) , 10.2353/AJPATH.2010.090945
M J Kreek, D M Novick, V Ghali, M Ochshorn, N Chiorazzi, T S Croxson, W D Mercer, Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients. Journal of Pharmacology and Experimental Therapeutics. ,vol. 250, pp. 606- 610 ,(1989)
Matthew J. Bellizzi, Shao-Ming Lu, Harris A. Gelbard, Protecting the synapse: evidence for a rational strategy to treat HIV-1 associated neurologic disease. Journal of Neuroimmune Pharmacology. ,vol. 1, pp. 20- 31 ,(2006) , 10.1007/S11481-005-9006-Y
Tracy Fischer-Smith, Jay Rappaport, Evolving paradigms in the pathogenesis of HIV-1-associated dementia. Expert Reviews in Molecular Medicine. ,vol. 7, pp. 1- 26 ,(2005) , 10.1017/S1462399405010239
Sheelagh FRAME, Philip COHEN, GSK3 takes centre stage more than 20 years after its discovery. Biochemical Journal. ,vol. 359, pp. 1- 16 ,(2001) , 10.1042/0264-6021:3590001
J.A. Gurwell, A. Nath, Q. Sun, J. Zhang, K.M. Martin, Y. Chen, K.F. Hauser, Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro. Neuroscience. ,vol. 102, pp. 555- 563 ,(2001) , 10.1016/S0306-4522(00)00461-9
P.K. Peterson, G. Gekker, S. Hu, G. Cabral, J.R. Lokensgard, Cannabinoids and morphine differentially affect HIV-1 expression in CD4+ lymphocyte and microglial cell cultures Journal of Neuroimmunology. ,vol. 147, pp. 123- 126 ,(2004) , 10.1016/J.JNEUROIM.2003.10.026